Search This Blog

Friday, January 17, 2020

Regenxbio target upped to $58 from $55 by Morgan Stanley

Maintains Overweight
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)